Novartis AG NVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.31% | -6.57% | 5.25% | 17.11% | -18.24% |
| Total Depreciation and Amortization | 2.96% | 4.01% | 4.14% | 3.15% | 3.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.20% | -17.67% | -2.18% | 20.19% | 176.09% |
| Change in Net Operating Assets | -257.50% | -79.97% | -41.92% | -68.78% | 54.99% |
| Cash from Operations | -17.79% | -11.52% | 0.93% | 8.66% | 31.93% |
| Capital Expenditure | -11.42% | -11.34% | -17.73% | -13.32% | -23.31% |
| Sale of Property, Plant, and Equipment | -45.76% | -44.07% | -91.58% | -84.88% | -70.94% |
| Cash Acquisitions | -681.13% | -646.55% | -296.00% | 27.43% | 39.33% |
| Divestitures | 9.41% | -108.33% | -160.99% | -182.24% | 244.07% |
| Other Investing Activities | 95.77% | 91.73% | 80.15% | 85.44% | -44.40% |
| Cash from Investing | -221.93% | -234.68% | -169.62% | 35.09% | 6.96% |
| Total Debt Issued | 1,151.22% | 278.38% | 145.39% | -15.69% | -82.11% |
| Total Debt Repaid | -12.68% | 10.77% | 28.26% | -20.44% | 26.57% |
| Issuance of Common Stock | -21.74% | -23.08% | -16.13% | -10.00% | -23.33% |
| Repurchase of Common Stock | 40.42% | 37.93% | 15.85% | -10.57% | -53.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.99% | -15.99% | -12.03% | -2.54% | -2.54% |
| Other Financing Activities | 62.75% | 74.93% | -38.15% | -42.03% | -645.00% |
| Cash from Financing | 103.98% | 102.64% | 81.89% | -26.61% | -108.98% |
| Foreign Exchange rate Adjustments | -143.36% | -119.10% | 3,887.50% | 293.29% | 28.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.07% | 176.98% | 92.13% | 98.76% | -436.63% |